Ahmedabad-based Senores Pharmaceuticals is set to launch its IPO on December 20, with a price band of Rs 372-391. The issue includes a fresh equity sale of Rs 500 crore and an offer for sale of 21 lakh shares, totaling Rs 582 crore at the upper end. Bids can be made for a minimum of 38 shares, with 75% reserved for institutional buyers.
